Bridgefront Capital’s Kodiak Sciences KOD Stock Holding History

Bridgefront Capital’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,322	Closed	-$103K	–	382
2022 Q1	$103K	Buy	+13,322	New	+$520K	0.13%	234
2021 Q1	–	Sell	-2,867	Closed	-$421K	–	804
2020 Q4	$421K	Buy	+2,867	New	+$320K	0.14%	266

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Bridgefront Capital's KOD Position: Q2 2022 in Review

Bridgefront Capital sold out of Kodiak Sciences (KOD) in Q2 2022, closing a stake of 13,322 shares — an estimated $103K sold.

Bridgefront Capital first reported a position in KOD in Q4 2020 and held it in 2 quarters. The position peaked at $421K in Q4 2020. 131 funds tracked by Wall St. Rank hold KOD as of Q2 2022.

Bridgefront Capital reported no remaining Kodiak Sciences position as of Q2 2022 after selling out during the quarter.
Bridgefront Capital sold 13,322 Kodiak Sciences shares in Q2 2022, an estimated $103K.
Bridgefront Capital first reported a position in Kodiak Sciences in Q4 2020 and held it in 2 quarters.
Bridgefront Capital's Kodiak Sciences position peaked at $421K in Q4 2020.
131 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2022.

Based on Bridgefront Capital's 13F filing for Q2 2022, filed 12 Aug 2022.